21
Views
22
CrossRef citations to date
0
Altmetric
Urology: Original clinical scientific reports

Tamsulosin and Chlormadinone for the Treatment of Benign Prostatic Hyperplasia

, , , , , & show all
Pages 379-385 | Received 06 Apr 1994, Accepted 06 Oct 1995, Published online: 15 Feb 2010

REFERENCES

  • Boyarsky S, Jones G, Paulson DF, Prout GR. A new look at bladder neck obstruction by Food and Drug Administration regulators: guide lines for investigation of benign prostatic hypertrophy. Trans Am Genito-Urin Surg 1979; 68: 29–31.
  • Caine M, Pfau A, Perlberg S. The use of alpha-adrenergic blockers in benign prostatic obstruction. Br J Urol 1976; 48: 255–263.
  • Chapple CR, Christmas TJ, Milroy EJG. A twelve-week placebo controlled study of prazosin in the treatment of prostatic obstruction. Urol Int 1990; 45: 47–55.
  • Gormley GJ, Stoner E, Bruskewitzs RG, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992; 327: 1185–1191.
  • Gup DI, Shapiro E, Baumann M, Lepor H. Autonomic receptors in human prostate adenomas. J Urol 1990; 143: 179–185.
  • Jimenez Cruz JF. The role of alpha-adrenergic blockers in the treatment of prostatic hypertrophy. Drugs of Today 1993; 29: 343–349.
  • Jonler M, Riehmann, Bruskewitz R. Benign prostatic hyperplasia: current pharmacological treatment. Drugs 1994; 47: 66–81.
  • Kawabe K, Niijima T. Use of an alpha blocker, YM-12617, in micturition difficulty. Urol Int 1987; 42: 280–284.
  • Kunishima Y, Kawabe K, Niijima T, Honda K, Tanaka T. A pharmacological study of alpha adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra. J Urol 1985; 134: 396–398.
  • Lepor H. Role of α-adrenergic blockers in the treatment of benign prostatic hyperplasia. Prostate 1990; (Suppl 3): 75–84.
  • Lepor H, Gup DI, Baumann M, Shapiro E. Comparison of alpha 1 adrenoceptors in the prostate adenoma and prostate capsule of men with symptomatic and asymptomatic benign prostatic hyperplasia. Br J Urol 1991; 67: 493–498.
  • MacGrath JC, Grown CM, Wilson VG. α-Adrenoceptors, in receptor data for biological experiments: in Doods, et al. (eds.): A guide to drug selectivity. New York: Ellis Horwood, 1991, pp 13–18.
  • Price DT, Schwin JW, Lomasney JW, Allen LP, Caron MG, Lefkowittz RJ. Identification, quantification, and localization of mRNA for the three distinct alpha 1 adrenergic receptor subtypes in human prostate. J Urol 1993; 150: 546–551.
  • Ruutu ML, Hansson E, Juusela HE, et al. Efficacy and side-effects of prazosin as a systemic treatment of benign prostatic obstruction. Scand J Urol Nephrol 1991; 25: 15–19.
  • Shida K. Fundamental and clinical study of anti-androgens. Androgen-dependency of prostatic tumors and clinical application of anti-androgens. Asian Med J 1981; 24: 747–777.
  • Siroky MB, Olsson CA, Krane RJ. The flow rate nomogram: II. Clinical correlation. J Urol 1980; 123: 208–210.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.